Author:
Fan Guangchun,Tao Zhengxin,Chen Shang,Zhang Huahua,Yu Rongjie
Publisher
China Science Publishing & Media Ltd.
Subject
General Medicine,Biochemistry,Biophysics
Reference41 articles.
1. Pisegna JR, Oh DS. Pituitary adenylate cyclase-activating polypeptide: a novel peptide with protean implications. Curr Opin Endocrinol Diabetes Obesity, 2007, 58-62.
2. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, et al. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 1998, 50: 265–270.
3. Lee EH, Seo SR. Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases. BMB Rep, 2014, 369-375.
4. Reglodi D, Atlasz T, Szabo E, Jungling A, Tamas A, Juhasz T, Fulop BD. PACAP deficiency as a model of aging. GeroScience, 2018, 437-452.
5. Kasica N, Podlasz P, Sundvik M, Tamas A, Reglodi D, Kaleczyc J. Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against oxidative stress in zebrafish hair cells. Neurotox Res, 2016, 633-647.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献